Cardiovascular Drugs and Therapy

, Volume 20, Issue 6, pp 463–469

Molecular Mechanisms of Cross-talk between Thyroid Hormone and Peroxisome Proliferator Activated Receptors: Focus on the Heart


DOI: 10.1007/s10557-006-0643-z

Cite this article as:
Hyyti, O.M. & Portman, M.A. Cardiovasc Drugs Ther (2006) 20: 463. doi:10.1007/s10557-006-0643-z


Thyroid hormone receptors (TR) and peroxisome proliferator activated receptors (PPAR) regulate cardiac metabolism. Numerous studies have examined TR and PPAR function since PPAR was first discovered in the early 1990s, however few have evaluated TR and PPAR interactions. Although ligands for these members of the nuclear steroid receptor family are under evaluation for treatment of congestive heart failure and various metabolic diseases, their interactions have not been investigated in detail in heart. These interactions are remarkably complicated. Nevertheless, their identification and elucidation is extremely important for further development of specific drugs. We review here the fundamental ways TRs and PPARs are regulated and how their cross-talk patterns mediate transcription of their target genes.

Key words

thyroid hormone receptor peroxisome proliferator activated receptor heart metabolism 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science + Business Media, LLC 2006

Authors and Affiliations

  1. 1.Division of Cardiology, Department of PediatricsChildren’s Hospital & Regional Medical CenterSeattleUSA
  2. 2.Department of PediatricsUniversity of WashingtonSeattleUSA

Personalised recommendations